Lowering Drug Costs for Families Act misses the mark on making savings a reality for patients
July 26, 2023 (WASHINGTON, D.C.) The...
Latest news
BIDEN ADMINISTRATION STATE OF THE UNION MISSES OPPORTUNITIES TO ADDRESS THE REALITIES FOR CHRONIC DISEASE PATIENTS
More than half of US adults are living with one or more chronic conditions
February 8, 2023 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released the following statement from Chair Ken Thorpe in response to President Biden’s State of the Union
Press release
Feb 8,2023
ADVANCING HEALTH EQUITY, IMPROVING HEALTH OUTCOMES FOR ALL COULD SAVE U.S. $3.8 TRILLION
New Data Elevate Access to Primary Care and Improved Adherence as Immediate Opportunities for Savings
November 2, 2022 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released new data and analysis on the economic impact of achieving health equity in chronic
Press release
Nov 2,2022
Legislation Still Falls Short for Patients
Medicare patients with chronic disease remain in desperate need of real cost relief
August 09, 2022 08:50 AM Eastern Daylight Time
WASHINGTON - The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the
Press release
Aug 9,2022
LATEST PRESCRIPTION DRUG PRICE NEGOTIATION DRAFT TAKES TWO STEPS BACK FOR SENIORS
July 6, 2022 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement today regarding the Prescription Drug Pricing Reform proposal aiming to lower drug prices through government negotiation under Medicare:
“More than half of U.S. adults are
Press release
Jul 6,2022
NEW ANALYSIS FINDS ACCELERATED APPROVAL DRUGS DO NOT DRIVE MEDICAID SPENDING
Findings Published in Health Affairs Forefront
Precedent-setting policies to restrict access to accelerated approval drugs do not reduce health care spending but rather harm America’s most vulnerable patients
June 3, 2022 (WASHINGTON, D.C.) The Partnership to Fight
Press release
Jun 3,2022
Compromising Patient Access Is Not a Path Forward for Alzheimer’s Disease
CMS decision harms current and future treatment options for Alzheimer's and other chronic disease populations
April 8, 2022 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement from Chair Ken Thorpe regarding the Centers for Medicare and
Press release
Apr 8,2022
Never Undermine Scientific Discovery — Especially Now
March 01, 2022
Real Clear Policy
By Kenneth E. Thorpe
While the pandemic is by no means over, Covid-19 isn't the only threat to public health we face. In fact, it might not even be our most serious challenge.
Despite the tragic loss of more than 2,000 American
OP-ED
Mar 1,2022
Oregon's Medicaid waiver hurts chronic disease patients
By Kenneth E. Thorpe
February 3, 2022
More than half of Oregon's population -- nearly 2.3 million people -- is living with at least one chronic disease.[1][2] A disproportionate share rely on Medicaid to provide them the medications they need, and are beneficiaries because of
OP-ED
Feb 3,2022
Driving Health Care Reforms Now Will Impact Future Generations, Getting It Right Is Critical For Millions of Families Managing Chronic Conditions
WASHINGTON (December 7, 2021) -- Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement following President Biden’s remarks on the costs of prescription drugs.
“Especially as Americans are still very much navigating a path forward from
Press release
Dec 7,2021
Any Drug Pricing Compromise Must Lower Costs and Preserve Access to Innovative Therapies. Congress Can, and Should, Do Both.
WASHINGTON, D.C. (November 3, 2021) Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement on the drug pricing plan that Congress is considering.
“While we wait to see the details of this plan, Senate negotiators have apparently taken some
Press release
Nov 3,2021